Display Settings:

Format

Send to:

Choose Destination

    Mol Cell. 2001 Sep;8(3):671-82.

    The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.

    Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massagué J.

    Laboratory of Molecular Biophysics, Rockefeller University, New York, NY 10021, USA.

    Comment in:

    The type I TGF beta receptor (T beta R-I) is activated by phosphorylation of the GS region, a conserved juxtamembrane segment located just N-terminal to the kinase domain. We have studied the molecular mechanism of receptor activation using a homogeneously tetraphosphorylated form of T beta R-I, prepared using protein semisynthesis. Phosphorylation of the GS region dramatically enhances the specificity of T beta R-I for the critical C-terminal serines of Smad2. In addition, tetraphosphorylated T beta R-I is bound specifically by Smad2 in a phosphorylation-dependent manner and is no longer recognized by the inhibitory protein FKBP12. Thus, phosphorylation activates T beta R-I by switching the GS region from a binding site for an inhibitor into a binding surface for substrate. Our observations suggest that phosphoserine/phosphothreonine-dependent localization is a key feature of the T beta R-I/Smad activation process.

    PMID: 11583628 [PubMed - indexed for MEDLINE]

    Publication Types, MeSH Terms, Substances, Secondary Source ID, Grant Support

    Publication Types:

    MeSH Terms:

    Substances:

    Secondary Source ID:

    Grant Support:

    Supplemental Content

    Click here to read

    Structures reported by this article

    Patient drug information

    • Tacrolimus (Prograf®)

      Tacrolimus is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received kidney, liver, or heart transplants. ...